updates in early stage non-small cell lung cancer
Published 2 years ago • 321 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
1:31
asco 2023: highlights in non-small cell lung cancer
-
2:00
updated data from phase 2 study of alectinib in alk–positive non–small–cell lung cancer
-
2:43
targeted therapy for early-stage lung cancer
-
0:38
addressing treatment strategies for limited stage small cell lung cancer
-
3:02
neoadjuvant and adjuvant immunotherapy in non-small cell lung cancer
-
1:01
targeting alk rearrangements in non-small cell lung cancer
-
1:38
moving forward: targeted therapies in early-stage lung cancer
-
0:50
implications of the ictan trial of icotinib for resected egfr-mutated stage ii-iiia nsclc
-
5:27
immunotherapy trial updates in nsclc from esmo 2020
-
1:30
immunotherapy in second-line treatment of non-small cell lung cancer
-
1:33
tracking non-small cell lung cancer evolution through therapy (rx) (tracerx)
-
1:02
early intervention neoadjuvant immunotherapy in lung cancer
-
3:55
chrysalis trial update in nsclc
-
1:06
lung cancer highlights from esmo 2022
-
2:00
lung cancer updates at asco 2021
-
3:53
lung cancer updates from ukof 2018
-
1:25
updates and unmet needs in alk-mutated lung cancer
-
1:52
is adjuvant immunotherapy necessary in non-small cell lung cancer?
-
1:41
data update in advanced stage nsclc